-
Domainex Reports Success of Lead COPD Compound and Secures £1.4m Funding
Domainex Reports Success of its Lead Compound in Pre-clinical Model of COPD and Secures £1.4m Biomedical Catalyst Award
-
Cambridge Research Biochemicals and Key Organics Announce Exclusive Global Agreement
Cambridge Research Biochemicals and Key Organics announce an exclusive global supply & marketing agreement for peptides.
-
Cambridge Research Biochemicals Renews Contract with Medical Research Council
Cambridge Research Biochemicals renews Supply Contract with the Medical Research Council for a fourth year
-
LBIC News Spring 2014: MedCity, Focus on Cogent, SynBioBeta
LBIC News Spring 2014 issue now online, featuring MedCity, Focus on Cogent, Social Media & Biotech, plus client interviews, news and successes.
-
Domainex programme shows great promise for the treatment of inflammatory diseases
Domainex programme shows great promise for the treatment of inflammatory diseases, such as Chronic Obstructive Pulmonary Disease (COPD)
-
BioTools Inc. Co-founder Professor Laurence Nafie Receives Major Scientific Award
BioTools Inc. Co founder and Chief Scientific Officer Professor Laurence Nafie receives major scientific award
-
SynBioBeta Announces Lean Launch Legend Steve Blank and the Silicon Valley Roundtable
SynBioBeta Announces Lean Launch Legend Steve Blank and the Silicon Valley Roundtable, the conference for Synthetic Biology startups, industry and investors
-
Harley Street Cancer Concierge launches fast track cancer diagnostic services
Harley Street Cancer Concierge launches fast track cancer diagnostic services with new services designed to reduce patient anxiety and speed access to treatment.
-
SYNBIOBETA LONDON 2014
SYNBIOBETA LONDON 2014 – The Conference For Synthetic Biology Startups, Industry and Investors – Keynote speaker – Rt Hon David Willetts MP, Minister for Universities and Science
-
University of Edinburgh and Selcia in £2.5 m bid to develop new sleeping sickness drugs
University of Edinburgh and Selcia in £2.5 m bid to develop new drugs to target sleeping sickness the devastating tropical disease that threatens almost 70 million people in Africa.